Stocks & AI: what moved, and why Inspired by zlio.com

JNJ Johnson & Johnson

NYSE · Healthcare

JNJ chart by TradingView

Tue, Nov 10 0.9× volume -0.5%
Mon, Nov 9 0.9× volume +2.1%
Fri, Nov 6 1.2× volume +1.4%
Thu, Nov 5 1.3× volume -1.4%
Wed, Nov 4 1.3× volume +3.8%
Tue, Nov 3 0.9× volume -1.6%
Mon, Nov 2 1.1× volume -1.0%

Top holding of JNJY.TO 125.6%, IHE 21.3%, XLV 9.5%, IYH 9.5%, VHT 9.0%, FHLC 8.8%, IXJ 7.1%, MHCD.TO 6.5%

News this week

  1. California Jury Awards $34.21 Million in Johnson & Johnson Talc-Asbestos Mesothelioma Case
    AB.H.V JNJ -0.5%PR Newswire ·
  2. Johnson & Johnson reports 73% PSA response rate with investigational pasritamig-based immunotherapy combination in advanced prostate cancer
    JNJ -0.5%PR Newswire ·
  3. J&J posts late-stage trial win for plaque psoriasis pill in psoriatic arthritis
    JNJ -0.5%2 sourcesSeeking Alpha ·
  4. Johnson & Johnson announces new Phase 2 nipocalimab study data in Sjögren's disease that reveal insights on importance of symptom improvements most valued by patients
    JNJ -0.5%PR Newswire ·
  5. J&J gains approval of Rybrevant Faspro for head and neck cancer
    HALO +0.1% JNJ -0.5%3 sourcesSeeking Alpha ·
  6. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ
    JNJ -0.5%PR Newswire ·